The Asia Pacific Infant Phototherapy Devices Market would witness market growth of 6.4% CAGR during the forecast period (2018 – 2024). Phototherapy is widely used in minimizing bilirubin (the compound that leads to jaundice) levels in infants. The infant is made to lie in a plastic crib, exposing the infant to a type of light which is absorbed by the infant. With this process, the bilirubin in the infant’s body gets converted into a much simpler water-soluble form which is easily excreted through stool and urine. Growing prevalence of neonatal jaundice, effective phototherapy treatment, and technological advancements in the field of infant phototherapy are the factors that drive the infant phototherapy devices market. However, side effects related to the use of phototherapy treatment would limit the market growth.
Based on Configuration, the market is segmented into Mobile Device and Fixed Device. Based on Light Source, the market is segmented into Light-Emitting Diodes (LEDs), Fluorescent Lamps (FL), Quartz Halogen Lamps and Gas Discharge Tubes. Based on End User, the market is segmented into Hospital and Neonatal Clinics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include D-Rev, AVI Healthcare Pvt. Ltd., Natus Medical Incorporated, GE Healthcare (A healthcare division Of GE Company), Atom Medical Corporation, Ibis Medical Equipment & Systems Pvt. Ltd., Ningbo David Medical Device Co. Ltd., Phoenix Medical Systems (P) Ltd., Weyer GmbH, Zhengzhou Dison Instrument and Meter Co. Ltd.